Cuproptosis: a new form of programmed cell death

Yongqiang Wang,Long Zhang,Fangfang Zhou

DOI: https://doi.org/10.1038/s41423-022-00866-1

2022-04-22

Cellular and Molecular Immunology

Abstract:Cellular & Molecular Immunology, Published online: 22 April 2022; doi:10.1038/s41423-022-00866-1Cuproptosis: a new form of programmed cell death

immunology

What problem does this paper attempt to address?

Cuproptosis: a copper-triggered modality of mitochondrial cell death

Daolin Tang,Xin Chen,Guido Kroemer

DOI: https://doi.org/10.1038/s41422-022-00653-7

IF: 44.1

2022-03-30

Cell Research

Abstract:Cell Research, Published online: 30 March 2022; doi:10.1038/s41422-022-00653-7Cuproptosis: a copper-triggered modality of mitochondrial cell death

cell biology
Cuproptosis in cancer: biological implications and therapeutic opportunities

Liping Li,Houfeng Zhou,Chenliang Zhang

DOI: https://doi.org/10.1186/s11658-024-00608-3

2024-06-27

Cellular & Molecular Biology Letters

Abstract:Cuproptosis, a newly identified copper (Cu)-dependent form of cell death, stands out due to its distinct mechanism that sets it apart from other known cell death pathways. The molecular underpinnings of cuproptosis involve the binding of Cu to lipoylated enzymes in the tricarboxylic acid cycle. This interaction triggers enzyme aggregation and proteotoxic stress, culminating in cell death. The specific mechanism of cuproptosis has yet to be fully elucidated. This newly recognized form of cell death has sparked numerous investigations into its role in tumorigenesis and cancer therapy. In this review, we summarized the current knowledge on Cu metabolism and its link to cancer. Furthermore, we delineated the molecular mechanisms of cuproptosis and summarized the roles of cuproptosis-related genes in cancer. Finally, we offered a comprehensive discussion of the most recent advancements in Cu ionophores and nanoparticle delivery systems that utilize cuproptosis as a cutting-edge strategy for cancer treatment.

cell biology,biochemistry & molecular biology
Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway

Su-Ran Li,Lin-Lin Bu,Lulu Cai

DOI: https://doi.org/10.1038/s41392-022-01014-x

IF: 39.3

2022-05-14

Signal Transduction and Targeted Therapy

Abstract:Signal Transduction and Targeted Therapy, Published online: 13 May 2022; doi:10.1038/s41392-022-01014-x Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway

biochemistry & molecular biology,cell biology
Research progress on cuproptosis in cancer

Qingbo Feng,Chenyu Huo,Maijian Wang,Handong Huang,Xingbin Zheng,Ming Xie

DOI: https://doi.org/10.3389/fphar.2024.1290592

IF: 5.6

2024-01-31

Frontiers in Pharmacology

Abstract:Cuproptosis is a recently discovered form of cell death that is mediated by copper (Cu) and is a non-apoptotic form of cell death related to oligomerization of lipoylated proteins and loss of Fe-S protein clusters. Since its discovery, cuproptosis has been extensively studied by researchers for its mechanism and potential applications in the treatment of cancer. Therefore, this article reviews the specific mechanism of cuproptosis currently studied, as well as its principles and strategies for use in anti-cancer treatment, with the aim of providing a reference for cuproptosis-based cancer therapy.

pharmacology & pharmacy
Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives

Chenliang Zhang,Tingting Huang,Liping Li

DOI: https://doi.org/10.1186/s13045-024-01589-8

IF: 28.5

2024-08-18

Journal of Hematology & Oncology

Abstract:Cuproptosis is a newly identified form of cell death induced by excessive copper (Cu) accumulation within cells. Mechanistically, cuproptosis results from Cu-induced aggregation of dihydrolipoamide S-acetyltransferase, correlated with the mitochondrial tricarboxylic acid cycle and the loss of iron–sulfur cluster proteins, ultimately resulting in proteotoxic stress and triggering cell death. Recently, cuproptosis has garnered significant interest in tumor research due to its potential as a crucial therapeutic strategy against cancer. In this review, we summarized the cellular and molecular mechanisms of cuproptosis and its relationship with other types of cell death. Additionally, we reviewed the current drugs or strategies available to induce cuproptosis in tumor cells, including Cu ionophores, small compounds, and nanomedicine. Furthermore, we targeted cell metabolism and specific regulatory genes in cancer therapy to enhance tumor sensitivity to cuproptosis. Finally, we discussed the feasibility of targeting cuproptosis to overcome tumor chemotherapy and immunotherapy resistance and suggested future research directions. This study suggested that targeting cuproptosis could open new avenues for developing tumor therapy.

oncology,hematology
Focus on cuproptosis: Exploring new mechanisms and therapeutic application prospects of cuproptosis regulation

Donglin Hao,Wei Luo,Yongmin Yan,Jing Zhou

DOI: https://doi.org/10.1016/j.biopha.2024.117182

Abstract:Cuproptosis is a novel form of regulated cell death, which plays an important role in the physiological and pathological processes of the human body. Despite the increasing research on cuproptosis-related genes (CRGs) and their correlation with diseases, the pathogenesis of cuproptosis-related diseases remains unclear. Furthermore, there is a lack of reviews on the emerging technologies for regulating cuproptosis in disease treatment. This study delves into the copper-induced cell death mechanism, distinguishing cuproptosis from mechanisms like oxidative stress, glutathione synthesis inhibition, and ubiquitin-proteasome system inhibition. Several long-standing mysteries of diseases such as Wilson's disease and Menkes disease may be attributed to the occurrence of cuproptosis. In addition, we also review the detection indicators related to cuproptosis, providing targets for the diagnosis of cuproptosis-related diseases, and summarize the application value of cuproptosis in tumor therapy to better elucidate the impact of copper in cell death and diseases, and thus to promote the application prospects and possible strategies of cuproptosis-related substances, such as copper ion chelators, copper ion carriers, and copper nanomaterials, in disease therapy.
Cuproptosis: Mechanism and Application in Lymphoma

Yubo Wang,Fengyue Yin,Quanyi Jin,Chen Liu,Zhongquan Qi,Dengyue Chen,Yiming Luo

DOI: https://doi.org/10.2174/0115680096296742240614100116

2024-07-11

Current Cancer Drug Targets

Abstract:The cell death field has profited from the increasing attention of the scientific community and has been shown to lie at the very basis of cancer initiation and progression. Cuproptosis is a recently proposed method of cell death in 2022, and it is different from any previously reported method. The principle is that copper ions lead to aggregation and instability of intracellular proteins. An increasing number of researchers are dedicated to enriching the mechanism of cuproptosis and exploring its relationship with cancer. Studies have found that intracellular copper levels have an impact on the occurrence and development of lymphoma. The complexity of lymphoma and the limitations of treatment necessitate in-depth studies of the disease. We will review the mechanism of cuproptosis and its potential in lymphoma therapy.

oncology
Cuproptosis: mechanisms and links with cancers

Jiaming Xie,Yannan Yang,Yibo Gao,Jie He

DOI: https://doi.org/10.1186/s12943-023-01732-y

IF: 37.3

2023-03-08

Molecular Cancer

Abstract:Cuproptosis was a copper-dependent and unique kind of cell death that was separate from existing other forms of cell death. The last decade has witnessed a considerable increase in investigations of programmed cell death, and whether copper induced cell death was an independent form of cell death has long been argued until mechanism of cuproptosis has been revealed. After that, increasing number of researchers attempted to identify the relationship between cuproptosis and the process of cancer. Thus, in this review, we systematically detailed the systemic and cellular metabolic processes of copper and the copper-related tumor signaling pathways. Moreover, we not only focus on the discovery process of cuproptosis and its mechanism, but also outline the association between cuproptosis and cancers. Finally, we further highlight the possible therapeutic direction of employing copper ion ionophores with cuproptosis-inducing functions in combination with small molecule drugs for targeted therapy to treat specific cancers.

oncology,biochemistry & molecular biology
Recent progress of methods for cuproptosis detection

Ligang Zhang,Ruiting Deng,Raoqing Guo,Yawen Jiang,Yichen Guan,Caiyue Chen,Wudi Zhao,Guobin Huang,Lian Liu,Hongli Du,Dongsheng Tang

DOI: https://doi.org/10.3389/fmolb.2024.1460987

2024-09-04

Abstract:Varying from other identified cell death pathways, cuproptosis is a new type of regulated cell death characterized by excess Cu ions, abnormal aggregation of lipoylated proteins in TCA cycle, loss of Fe-S cluster proteins, upregulation of HSP70, leading to proteotoxic and oxidative stress. Cuproptosis is highly concerned by scientific community and as the field of cuproptosis further develops, remarkable progress has been made in the verification and mechanism of cuproptosis, and methods used to detect cuproptosis have been continuously improved. According to the characteristic changes of cuproptosis, techniques based on cell death verification, Cu content, morphology, molecular biology of protein levels of cuproptosis-related molecules and biochemical pathways of cuproptosis-related enzyme activity and metabolites of oxidative stress, lipoic acid, TCA cycle, Fe-S cluster proteins, oxidative phosphorylation, cell respiration intensity have been subject to cuproptosis verification and research. In order to further deepen the understanding of detecting cuproptosis, the principle and application of common cuproptosis detection methods are reviewed and categorized in cellular phenomena and molecular mechanism in terms of cell death, Cu content, morphology, molecular biology, biochemical pathways with a flow chart. All the indicating results have been displayed in response to the markers of cuproptosis, their advantages and limitations are summaried, and comparison of cuproptosis and ferroptosis detection is performed in this study. Our collection of methods for cuproptosis detection will provide a great basis for cuproptosis verification and research in the future.
Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope

Xiaojie Zhang,Bufu Tang,Jinhua Luo,Yang Yang,Qiaoyou Weng,Shiji Fang,Zhongwei Zhao,Jianfei Tu,Minjiang Chen,Jiansong Ji

DOI: https://doi.org/10.1186/s12943-024-02130-8

IF: 37.3

2024-11-21

Molecular Cancer

Abstract:Normal life requires cell division to produce new cells, but cell death is necessary to maintain balance. Dysregulation of cell death can lead to the survival and proliferation of abnormal cells, promoting tumor development. Unlike apoptosis, necrosis, and autophagy, the newly recognized forms of regulated cell death (RCD) cuproptosis, ferroptosis, and PANoptosis provide novel therapeutic strategies for tumor treatment. Increasing research indicates that the death of tumor and immune cells mediated by these newly discovered forms of cell death can regulate the tumor microenvironment (TME) and influence the effectiveness of tumor immunotherapy. This review primarily elucidates the molecular mechanisms of cuproptosis, ferroptosis, and PANoptosis and their complex effects on tumor cells and the TME. This review also summarizes the exploration of nanoparticle applications in tumor therapy based on in vivo and in vitro evidence derived from the induction or inhibition of these new RCD pathways.

oncology,biochemistry & molecular biology
Novel insights into cuproptosis inducers and inhibitors

Ligang Zhang,Ruiting Deng,Lian Liu,Hongli Du,Dongsheng Tang

DOI: https://doi.org/10.3389/fmolb.2024.1477971

IF: 6.113

2024-11-28

Frontiers in Molecular Biosciences

Abstract:Cuproptosis is a new pattern of Cu-dependent cell death distinct from classic cell death pathways and characterized by aberrant lipoylated protein aggregation in TCA cycle, Fe-S cluster protein loss, HSP70 elevation, proteotoxic and oxidative stress aggravation. Previous studies on Cu homeostasis and Cu-induced cell death provide a great basis for the discovery of cuproptosis. It has gradually gathered enormous research interests and large progress has been achieved in revealing the metabolic pathways and key targets of cuproptosis, due to its role in mediating some genetic, neurodegenerative, cardiovascular and tumoral diseases. In terms of the key targets in cuproptosis metabolic pathways, they can be categorized into three types: oxidative stress, mitochondrial respiration, ubiquitin-proteasome system. And strategies for developing cuproptosis inducers and inhibitors involved in these targets have been continuously improved. Briefly, based on the essential cuproptosis targets and metabolic pathways, this paper classifies some relevant inducers and inhibitors including small molecule compounds, transcription factors and ncRNAs with the overview of principle, scientific and medical application, in order to provide reference for the cuproptosis study and target therapy in the future.

biochemistry & molecular biology
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance

Yumin Wang,Yongming Chen,Junjing Zhang,Yihui Yang,Joshua S Fleishman,Yan Wang,Jinhua Wang,Jichao Chen,Yuanfang Li,Hongquan Wang,Joshua S. Fleishman

DOI: https://doi.org/10.1016/j.drup.2023.101018

IF: 22.841

2024-01-01

Drug Resistance Updates

Abstract:Cuproptosis is a newly identified form of cell death driven by copper. Recently, the role of copper and copper triggered cell death in the pathogenesis of cancers have attracted attentions. Cuproptosis has garnered enormous interest in cancer research communities because of its great potential for cancer therapy. Copper-based treatment exerts an inhibiting role in tumor growth and may open the door for the treatment of chemotherapy-insensitive tumors. In this review, we provide a critical analysis on copper homeostasis and the role of copper dysregulation in the development and progression of cancers. Then the core molecular mechanisms of cuproptosis and its role in cancer is discussed, followed by summarizing the current understanding of copper-based agents (copper chelators, copper ionophores, and copper complexes-based dynamic therapy) for cancer treatment. Additionally, we summarize the emerging data on copper complexes-based agents and copper ionophores to subdue tumor chemotherapy resistance in different types of cancers. We also review the small-molecule compounds and nanoparticles (NPs) that may kill cancer cells by inducing cuproptosis, which will shed new light on the development of anticancer drugs through inducing cuproptosis in the future. Finally, the important concepts and pressing questions of cuproptosis in future research that should be focused on were discussed. This review article suggests that targeting cuproptosis could be a novel antitumor therapy and treatment strategy to overcome cancer drug resistance.

pharmacology & pharmacy
Comprehensive analysis of the expression level, prognostic value, and immune infiltration of cuproptosis-related genes in human breast cancer

Jian Chen,Wei Cao,Yingliang Li,Jia Zhu

DOI: https://doi.org/10.1097/md.0000000000040132

IF: 1.6

2024-10-30

Medicine

Abstract:With 2.3 million new cases estimated in 2022, breast cancer is the second most common cancer worldwide only after lung cancer. [ 1 ] Moreover, its prevalence increases and gets younger every year, which brings a heavy burden to the world healthcare system. [ 2 ] Recently, the effects of some special cell death forms, like ferroptosis, pyroptosis, necroptosis, and autophagy, in breast cancer have been investigated with meaningful results. [ 3–6 ] As a newly discovered cell death form, cuproptosis was defined by Peter Tsvetkov et al in 2022. [ 7 ] There is now a gap in cuproptosis and breast cancer research.

medicine, general & internal
Cuproptosis: p53-regulated metabolic cell death?

Chen Xiong,Hong Ling,Qian Hao,Xiang Zhou

DOI: https://doi.org/10.1038/s41418-023-01125-0

IF: 12.067

2023-02-09

Cell Death and Differentiation

Abstract:Cuproptosis is a novel type of copper-induced cell death that primarily occurs in cells that utilize oxidative phosphorylation as the main metabolic pathway to produce energy. Copper directly associates with the lipoylated proteins of the tricarboxylic acid cycle, leading to the disulfide-bond-dependent aggregation of these lipoylated proteins, destabilization of the iron-sulfur cluster proteins, and consequent proteotoxic stress. Cancer cells prefer glycolysis (Warburg effect) to oxidative phosphorylation for producing intermediate metabolites and energy, thereby achieving resistance to cuproptosis. Interestingly, the tumor suppressor p53 is a crucial metabolic regulator that inhibits glycolysis and drives a metabolic switch towards oxidative phosphorylation in cancer cells. Additionally, p53 regulates the biogenesis of iron-sulfur clusters and the copper chelator glutathione, which are two critical components of the cuproptotic pathway, suggesting that this tumor suppressor might play a role in cuproptosis. Furthermore, the possible roles of mutant p53 in regulating cuproptosis are discussed. In this essay, we review the recent progress in the understanding of the mechanism underlying cuproptosis, revisit the roles of p53 in metabolic regulation and iron-sulfur cluster and glutathione biosynthesis, and propose several potential mechanisms for wild-type and mutant p53-mediated cuproptosis regulation.

cell biology,biochemistry & molecular biology
Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?

Ruiwen Zhao,Olga Sukocheva,Edmund Tse,Margarita Neganova,Yulia Aleksandrova,Yufei Zheng,Hao Gu,Deyao Zhao,SabbaRao V. Madhunapantula,Xiaorong Zhu,Junqi Liu,Ruitai Fan

DOI: https://doi.org/10.1186/s12964-024-01743-2

IF: 7.525

2024-07-29

Cell Communication and Signaling

Abstract:Copper is an important metal micronutrient, required for the balanced growth and normal physiological functions of human organism. Copper-related toxicity and dysbalanced metabolism were associated with the disruption of intracellular respiration and the development of various diseases, including cancer. Notably, copper-induced cell death was defined as cuproptosis which was also observed in malignant cells, representing an attractive anti-cancer instrument. Excess of intracellular copper leads to the aggregation of lipoylation proteins and toxic stress, ultimately resulting in the activation of cell death. Differential expression of cuproptosis-related genes was detected in normal and malignant tissues. Cuproptosis-related genes were also linked to the regulation of oxidative stress, immune cell responses, and composition of tumor microenvironment. Activation of cuproptosis was associated with increased expression of redox-metabolism-regulating genes, such as ferredoxin 1 (FDX1), lipoic acid synthetase (LIAS), lipoyltransferase 1 (LIPT1), dihydrolipoamide dehydrogenase (DLD), drolipoamide S-acetyltransferase (DLAT), pyruvate dehydrogenase E1 subunit alpha 1 (PDHA1), and pyruvate dehydrogenase E1 subunit beta (PDHB)). Accordingly, copper-activated network was suggested as an attractive target in cancer therapy. Mechanisms of cuproptosis and regulation of cuproptosis-related genes in different cancers and tumor microenvironment are discussed in this study. The analysis of current findings indicates that therapeutic regulation of copper signaling, and activation of cuproptosis-related targets may provide an effective tool for the improvement of immunotherapy regimens.

cell biology
Comprehensive Investigation into Cuproptosis in the Characterization of Clinical Features, Molecular Characteristics, and Immune Situations of Clear Cell Renal Cell Carcinoma.

Bao Wang,Qiang Song,Yuang Wei,Xiangzheng Wu,Tian Han,Hengtao Bu,Sensheng Tang,Jian Qian,Pengfei Shao

DOI: https://doi.org/10.3389/fimmu.2022.948042

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:Background:Copper-induced cell death has been widely investigated in human diseases as a form of programmed cell death (PCD). The newly recognized mechanism underlying copper-induced cell death provided us creative insights into the copper-related toxicity in cells, and this form of PCD was termed cuproptosis.Methods:Through consensus clustering analysis, ccRCC patients from TCGA database were classified into different subgroups with distinct cuproptosis-based molecular patterns. Analyses of clinical significance, long-term survival, and immune features were performed on subgroups accordingly. The cuproptosis-based risk signature and nomogram were constructed and validated relying on the ccRCC cohort as well. The cuproptosis scoring system was generated to better characterize ccRCC patients. Finally, in vitro validation was conducted using ccRCC clinical samples and cell lines.Result:Patients from different subgroups displayed diverse clinicopathological features, survival outcomes, tumor microenvironment (TME) characteristics, immune-related score, and therapeutic responses. The prognostic model and cuproptosis score were well validated and proved to efficiently distinguish the high risk/score and low risk/score patients, which revealed the great predictive value. The cuproptosis score also tended out to be intimately associated with the prognosis and immune features of ccRCC patients. Additionally, the hub cuproptosis-associated gene (CAG) FDX1 presented a dysregulated expression pattern in human ccRCC samples, and it was confirmed to effectively promote the killing effects of copper ionophore elesclomol as a direct target. In vitro functional assays revealed the prominent anti-cancer role of FDX1 in ccRCC.Conclusion:Cuproptosis played an indispensable role in the regulation of TME features, tumor progression, and long-term prognosis of ccRCC.
Cuproptosis: potential new direction in diabetes research and treatment

Jiashu Qu,Yifan Wang,Qiuyue Wang

DOI: https://doi.org/10.3389/fendo.2024.1344729

IF: 6.055

2024-06-05

Frontiers in Endocrinology

Abstract:Cuproptosis, a recently discovered form of cell death, stems from an overabundance of copper ions infiltrating mitochondria. These ions directly engage lipoylated proteins, prompting their oligomerization and subsequent loss of iron-sulfur clusters. This sequence induces proteotoxic stress, ultimately culminating in cell death. Type 2 diabetes, a chronic metabolic disorder resulting from a complex interplay of genetic and environmental factors, has not yet been fully understood in terms of its etiology and pathogenesis. Intricately, it is linked to various modalities of cell death, including mitochondrial autophagy, apoptosis, pyroptosis, and ferroptosis. Studies have discovered impaired copper metabolism in individuals with Type 2 diabetes, hinting at a unique role for copper homeostasis in the progression of the disease. To this end, the present research aims to delineate the potential correlation between cuproptosis and Type 2 diabetes by exhaustively reviewing the existing literature. By synthesizing relevant research on cuproptosis, the paper intends to lay the groundwork for a thorough exploration of the pathogenesis of Type 2 diabetes and the development of targeted therapeutic interventions. The ultimate objective is to facilitate a deeper understanding of Type 2 diabetes and to identify novel therapeutic strategies associated with cuproptosis.

endocrinology & metabolism
Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases

Yurong Zou,Shukun Wu,Xingli Xu,Xiaoqiu Tan,Shuang Yang,Tangting Chen,Jiong Zhang,Shengqiang Li,Wei Li,Fang Wang

DOI: https://doi.org/10.1016/j.intimp.2024.112075

IF: 5.714

2024-04-26

International Immunopharmacology

Abstract:Cuproptosis has recently been identified as a novel regulatory mechanism of cell death. It is characterized by the accumulation of copper in mitochondria and its binding to acylated proteins. These characteristics lead to the downregulation of iron-sulfur cluster proteins and protein toxicity stress, ultimately resulting in cell death. Cuproptosis is distinct from other types of cell death, including necrosis, apoptosis, ferroptosis, and pyroptosis. Cu induces oxidative stress damage, protein acylation, and the oligomerization of acylated TCA cycle proteins. These processes lead to the downregulation of iron-sulfur cluster proteins and protein toxicity stress, disrupting cellular Cu homeostasis, and causing cell death. Cuproptosis plays a significant role in the development and progression of various kidney diseases such as acute kidney injury, chronic kidney disease, diabetic nephropathy, kidney transplantation, and kidney stones. On the one hand, inducers of cuproptosis, such as disulfiram (DSF), chloroquinolone, and elesclomol facilitate cuproptosis by promoting cell oxidative stress. In contrast, inhibitors of Cu chelators, such as tetraethylenepentamine and tetrathiomolybdate, relieve these diseases by inhibiting apoptosis. To summarize, cuproptosis plays a significant role in the pathogenesis of kidney disease. This review comprehensively discusses the molecular mechanisms underlying cuproptosis and its significance in kidney diseases.

pharmacology & pharmacy,immunology
Cell death shapes cancer immunity: spotlighting PANoptosis

Lixia Gao,Chloe Shay,Yong Teng

DOI: https://doi.org/10.1186/s13046-024-03089-6

IF: 12.658

2024-06-16

Journal of Experimental & Clinical Cancer Research

Abstract:PANoptosis represents a novel type of programmed cell death (PCD) with distinctive features that incorporate elements of pyroptosis, apoptosis, and necroptosis. PANoptosis is governed by a newly discovered cytoplasmic multimeric protein complex known as the PANoptosome. Unlike each of these PCD types individually, PANoptosis is still in the early stages of research and warrants further exploration of its specific regulatory mechanisms and primary targets. In this review, we provide a brief overview of the conceptual framework and molecular components of PANoptosis. In addition, we highlight recent advances in the understanding of the molecular mechanisms and therapeutic applications of PANoptosis. By elucidating the complex crosstalk between pyroptosis, apoptosis and necroptosis and summarizing the functional consequences of PANoptosis with a special focus on the tumor immune microenvironment, this review aims to provide a theoretical basis for the potential application of PANoptosis in cancer therapy.

oncology
Unveiling Cuproptosis: Mechanistic insights, roles, and leading advances in oncology

Limei Zhang,Aihui Xie,Jinghxian Ma,Huilin Liu,Changchun Zeng

DOI: https://doi.org/10.1016/j.bbcan.2024.189180

2024-09-12

Abstract:Copper, a vital micronutrient, performs essential functions in numerous biological settings. Its disrupted metabolism is implicated in both the initiation of tumors and therapeutic interventions for cancer, underscoring the critical necessity of preserving copper homeostasis. Cuproptosis, a regulated cell death (RCD) modulated by copper, is activated in response to elevated copper concentrations, prompting an investigation into its implication in oncogenesis. Within this review, an exploration is conducted into copper dynamics and homeostasis maintenance within cells. Furthermore, it delves into the mechanisms underlying cuproptosis and its interplay with signaling pathways implicated in cancer. The potential synergy between cuproptosis and ferroptosis and its impact on tumor immunomodulation is discussed. Additionally, promising avenues for addressing cuproptosis in cancer involve assessing the utility of copper chelators and ionophores. By addressing pressing questions surrounding cuproptosis and outlining its pivotal role in cancer pathogenesis and treatment, this review propounds targeting cuproptosis as a promising frontier in antitumor therapy, potentially revolutionizing cancer treatment strategies.

Cuproptosis: a new form of programmed cell death

Cuproptosis: a copper-triggered modality of mitochondrial cell death

Cuproptosis in cancer: biological implications and therapeutic opportunities

Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway

Research progress on cuproptosis in cancer

Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives

Focus on cuproptosis: Exploring new mechanisms and therapeutic application prospects of cuproptosis regulation

Cuproptosis: Mechanism and Application in Lymphoma

Cuproptosis: mechanisms and links with cancers

Recent progress of methods for cuproptosis detection

Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope

Novel insights into cuproptosis inducers and inhibitors

Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance

Comprehensive analysis of the expression level, prognostic value, and immune infiltration of cuproptosis-related genes in human breast cancer

Cuproptosis: p53-regulated metabolic cell death?

Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?

Comprehensive Investigation into Cuproptosis in the Characterization of Clinical Features, Molecular Characteristics, and Immune Situations of Clear Cell Renal Cell Carcinoma.

Cuproptosis: potential new direction in diabetes research and treatment

Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases

Cell death shapes cancer immunity: spotlighting PANoptosis

Unveiling Cuproptosis: Mechanistic insights, roles, and leading advances in oncology